Table 1. The associations between TET2 expression and multiple clinicopathological parameters in HNSCC samples.
Clinicopathological parameters | Cases | TET2 | P value | |
---|---|---|---|---|
Low* | High | |||
Gender | 101 | 61 | 40 | |
Male | 52 | 31 | 21 | >0.9999 |
Female | 49 | 30 | 19 | |
Age | ||||
≤60 | 40 | 22 | 18 | 0.4098 |
>60 | 61 | 39 | 22 | |
Smoking | ||||
No | 73 | 42 | 31 | 0.3732 |
Yes | 28 | 19 | 9 | |
Alcohol use | ||||
No | 79 | 48 | 31 | >0.9999 |
Yes | 22 | 13 | 9 | |
Tumor size | ||||
T1–T2 | 68 | 38 | 30 | 0.0278# |
T3–T4 | 43 | 33 | 10 | |
Pathological grade | ||||
I | 59 | 35 | 24 | 0.8386 |
II–III | 42 | 26 | 16 | |
Cervical node metastasis | ||||
N0 | 66 | 42 | 24 | 0.3976 |
N+ | 35 | 19 | 16 | |
Clinical stage | ||||
I–II | 52 | 26 | 26 | 0.0413# |
III–IV | 49 | 35 | 14 |
*Both of patients with low and negative TET2 staining are stratified into low TET2 category for simplicity. #indicate statistical significance with P values less than 0.05. TET2, tet methylcytosine dioxygenase 2; HNSCC, head neck squamous cell carcinoma.